Literature DB >> 1953352

Effectiveness of 1,2,3,4-tetrahydro-9-aminoacridine (THA) as a pretreatment drug for protection of mice from acute diisopropylfluorophosphate (DFP) intoxication.

A Galli1, F Mori.   

Abstract

The protective action of 1,2,3,4-tetrahydro-9-aminoacridine (THA) against acute diisopropylfluorophosphate (DFP) intoxication was evaluated in mice by measuring the effects of the pretreatment of the animals with various doses of the drug on the DFP LD50. In the same experiments, the action of physostigmine and pyridostigmine were compared. THA at the doses 2.5, 5 and 7.5 mg/kg injected subcutaneously 15 min before DFP caused a dose-dependent increase in the DFP LD50, resulting in protection ratios equal to 3, 3.1 and 4.4, respectively, in the absence of atropine and 4.5, 8.6 and 14.5, respectively, in the absence of atropine and 4.5, 8.6 and 14.5, respectively, in the presence of atropine sulfate (17.4 mg/kg) therapy. Under the same experimental conditions, the protective ratios of 0.1 mg/kg physostigmine and pyridostigmine were 2.2 and 1.3, respectively, without atropine and 11.0 and 12.2, respectively, with atropine. The effectiveness of THA antidotal effect was inversely correlated to the time between pretreatment and DFP administration, being maximal when THA was injected 15 min before poisoning. In separate experiments, the time-course of acetylcholinesterase (AChE; EC 3.1.1.7) activity recovery was evaluated in the whole brain and diaphragm tissues of mice pretreated with THA (5 mg/kg) and physostigmine (0.1 mg/kg) 15 min before poisoning with DFP (8 mg/kg). At 10 min after DFP administration residual AChE activity in the brain averaged 4, 25 and 15% of that in controls in the animals pretreated with atropine alone, atropine plus THA or atropine plus physostigmine, respectively. At 24 h after poisoning, brain AChE activity averaged 34 and 47% of that in controls in the mice protected by THA and physostigmine, respectively. As for the diaphragm, AChE activity in THA-pretreated animals was 29% of controls 10 min after poisoning versus 8 and 23% in unprotected and physostigmine-pretreated animals, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1953352     DOI: 10.1007/bf01968968

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  25 in total

1.  Enzyme inhibiting action of tetrahydroaminoacridine and its structural fragments.

Authors:  P N KAUL
Journal:  J Pharm Pharmacol       Date:  1962-04       Impact factor: 3.765

2.  A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations.

Authors:  C D Johnson; R L Russell
Journal:  Anal Biochem       Date:  1975-03       Impact factor: 3.365

3.  Tacrine protection of acetylcholinesterase from inactivation by diisopropylfluorophosphate: a circular dichroism study.

Authors:  C S Wu; J T Yang
Journal:  Mol Pharmacol       Date:  1989-01       Impact factor: 4.436

4.  Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons.

Authors:  M A Rogawski
Journal:  Eur J Pharmacol       Date:  1987-10-06       Impact factor: 4.432

5.  The protection of animals against organophosphate poisoning by pretreatment with a carbamate.

Authors:  J J Gordon; L Leadbeater; M P Maidment
Journal:  Toxicol Appl Pharmacol       Date:  1978-01       Impact factor: 4.219

6.  A hydrophobic binding site in acetylcholinesterase.

Authors:  G M Steinberg; M L Mednick; J Maddox; R Rice
Journal:  J Med Chem       Date:  1975-11       Impact factor: 7.446

7.  The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro.

Authors:  A J Hunter; T K Murray; J A Jones; A J Cross; A R Green
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

8.  Protection against diisopropylfluorophosphate intoxication by meptazinol.

Authors:  A Galli; A Mazri
Journal:  Toxicol Appl Pharmacol       Date:  1988-09-30       Impact factor: 4.219

Review 9.  Tacrine in the treatment of Alzheimer's disease. A clinical update and recent pharmacologic studies.

Authors:  W K Summers; K H Tachiki; A Kling
Journal:  Eur Neurol       Date:  1989       Impact factor: 1.710

10.  Effectiveness of physostigmine as a pretreatment drug for protection of rats from organophosphate poisoning.

Authors:  S S Deshpande; G B Viana; F C Kauffman; D L Rickett; E X Albuquerque
Journal:  Fundam Appl Toxicol       Date:  1986-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.